Kaiser Joint Compound (Asbestos-Containing Formulation)

Product Description

Kaiser Gypsum Company was a major American manufacturer of gypsum-based building products, operating for decades as a significant supplier to the residential and commercial construction markets. Among its product lines, Kaiser produced joint compound — a finishing material used to seal, smooth, and finish the seams between drywall panels. This type of compound, also referred to as drywall mud, was a standard component of interior construction throughout much of the twentieth century.

Kaiser joint compound was formulated to be spread over taped drywall joints and then sanded smooth once dry, creating the flat, seamless wall surfaces characteristic of modern interior construction. The product was sold in powdered and pre-mixed forms, packaged for professional tradespeople and general contractors working on everything from single-family homes to large commercial buildings. As with many construction materials produced during this era, certain formulations of Kaiser joint compound contained asbestos as an additive ingredient — a fact that would carry serious long-term health consequences for those who handled the product.

Kaiser Gypsum Company’s asbestos liabilities eventually led to significant legal and financial proceedings, culminating in the establishment of a dedicated trust fund to compensate individuals harmed by exposure to the company’s asbestos-containing products.

Asbestos Content

Asbestos was incorporated into joint compound formulations by Kaiser Gypsum and other manufacturers during a period when the mineral was widely used in building products for its binding, fire-resistant, and textural properties. In joint compound, asbestos fibers — most commonly chrysotile (white asbestos) — served as a reinforcing agent that improved the workability and durability of the material. Asbestos also helped reduce cracking as the compound dried and cured.

The use of asbestos in joint compound was common across the industry during the mid-twentieth century. Regulatory changes and growing awareness of asbestos-related disease prompted manufacturers to phase out asbestos-containing formulations, but products produced before those transitions remained in buildings and job sites, continuing to pose exposure risks during renovation, demolition, and repair work long after initial installation.

Documentation associated with Kaiser Gypsum’s bankruptcy proceedings and the subsequent establishment of the Kaiser Gypsum Company Asbestos PI Trust confirms the company’s manufacture and sale of asbestos-containing products, including joint compound formulations.

How Workers Were Exposed

Exposure to asbestos from Kaiser joint compound occurred primarily through the handling, application, and finishing of the product — activities that were routine parts of construction work for industrial workers and tradespeople across a range of settings.

Mixing and Preparation: Workers who mixed powdered joint compound created airborne dust containing asbestos fibers. Opening bags of dry compound and adding water generated clouds of fine particulate that workers breathed in enclosed or poorly ventilated spaces.

Application: Spreading joint compound over drywall seams with taping knives and finishing tools required close, repeated contact with the material. While wet compound presented a lower immediate fiber-release risk than dry handling, the application process still contributed to cumulative exposure over years of work.

Sanding and Dry Finishing: The most hazardous phase of joint compound work was sanding. Once dried, joint compound was sanded smooth using hand sanders or mechanical equipment. This process liberated substantial quantities of fine dust, including respirable asbestos fibers. Workers without adequate respiratory protection inhaled these fibers directly. Sanding was often performed in enclosed interior spaces with minimal ventilation, concentrating airborne fiber levels.

Adjacent Worker Exposure: Industrial workers, supervisors, inspectors, and other tradespeople working in proximity to drywall finishing operations were also exposed to asbestos-laden dust even if they were not directly handling the compound themselves. Asbestos fibers from sanding operations could remain suspended in the air and settle on surfaces throughout a worksite.

Re-entry and Renovation Work: Workers who later disturbed dried joint compound containing asbestos — through cutting, drilling, demolition, or renovation — faced renewed exposure. Because asbestos-containing joint compound was applied to walls and ceilings that remained in place for decades, the exposure risk extended well beyond the original construction period.

The health consequences associated with asbestos inhalation include mesothelioma, asbestosis, lung cancer, and other serious respiratory diseases. These conditions frequently have latency periods of ten to fifty years, meaning that workers exposed to Kaiser joint compound during earlier decades of construction may only now be receiving diagnoses.

Kaiser Gypsum Company Asbestos PI Trust

Kaiser Gypsum Company filed for bankruptcy protection in part due to the substantial volume of asbestos personal injury claims filed against it. As part of the resolution of those proceedings, the Kaiser Gypsum Company Asbestos PI Trust was established to provide compensation to individuals who suffered asbestos-related injuries caused by exposure to Kaiser Gypsum products, including Kaiser joint compound.

The trust operates under a Trust Distribution Procedure (TDP) that governs how claims are evaluated and compensated. Individuals seeking compensation through the trust must demonstrate that they were exposed to a Kaiser Gypsum asbestos-containing product and that they have been diagnosed with a qualifying asbestos-related disease.

Eligible Disease Categories typically recognized under asbestos trust fund claims include:

  • Mesothelioma — the most serious asbestos-caused cancer, affecting the lining of the lungs, abdomen, or heart
  • Lung cancer — with documented asbestos exposure as a contributing factor
  • Asbestosis — a chronic, progressive scarring of lung tissue caused by asbestos inhalation
  • Other asbestos-related diseases — including pleural disease and certain other conditions recognized under the trust’s TDP

Filing Eligibility: Claimants must provide documentation establishing product identification (connecting Kaiser joint compound to their exposure history), occupational or environmental exposure records, and medical evidence of diagnosis. Claims may be filed by injured workers directly or, in cases where the exposed individual has died, by surviving family members or estate representatives.

Some individuals with asbestos-related diagnoses linked to Kaiser joint compound may have legal options beyond the trust fund process, depending on the specific circumstances of their exposure, the involvement of other responsible parties, and the jurisdiction in which they reside. Workers exposed to multiple asbestos-containing products from different manufacturers may have claims against several trusts or may pursue litigation against solvent defendants not covered by a trust.

Individuals diagnosed with mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions who have a history of working with or around Kaiser joint compound are encouraged to consult with an attorney experienced in asbestos litigation to evaluate their eligibility for compensation through the Kaiser Gypsum Company Asbestos PI Trust or other available legal remedies.